流行病防范创新联盟（CEPI）和公平疫苗获取伙伴关系。
The Coalition for Epidemic Preparedness Innovations (CEPI) and the Partnerships of Equitable Vaccine Access.
机构信息
O'NEILL INSTITUTE FOR NATIONAL AND GLOBAL HEALTH LAW, WASHINGTON, DC, USA.
COLORADO STATE UNIVERSITY, FORT COLLINS, CO, USA.
出版信息
J Law Med Ethics. 2023;51(2):234-246. doi: 10.1017/jme.2023.85. Epub 2023 Sep 1.
Abstract
This article highlights and evaluates the role of CEPI and its contribution to global equitable access to COVID-19 vaccines through its established partnerships for vaccine development. The article adds to the understanding of how and when such partnerships can work for public health, especially under emergency citations.
摘要
本文强调并评估了 CEPI 在通过其建立的疫苗开发伙伴关系为全球公平获得 COVID-19 疫苗方面的作用。本文增加了对这些伙伴关系如何以及何时能够为公共卫生服务的理解，特别是在紧急情况下。
相似文献
1
The Coalition for Epidemic Preparedness Innovations (CEPI) and the Partnerships of Equitable Vaccine Access.流行病防范创新联盟（CEPI）和公平疫苗获取伙伴关系。
J Law Med Ethics. 2023;51(2):234-246. doi: 10.1017/jme.2023.85. Epub 2023 Sep 1.
2
CEPI: Driving Progress Toward Epidemic Preparedness and Response.CEPI：推动大流行防范和应对工作取得进展。
Epidemiol Rev. 2019 Jan 31;41(1):28-33. doi: 10.1093/epirev/mxz012.
3
Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.分配 COVID-19 疫苗：平衡国家和国际责任。
Milbank Q. 2021 Jun;99(2):450-466. doi: 10.1111/1468-0009.12494. Epub 2020 Dec 9.
4
Finding equipoise: CEPI revises its equitable access policy.寻找平衡：CEPI 修订其公平获取政策。
Vaccine. 2020 Feb 24;38(9):2144-2148. doi: 10.1016/j.vaccine.2019.12.055. Epub 2020 Jan 28.
5
Vaccines, inspiring innovation in health.疫苗，激发健康创新。
Vaccine. 2018 Nov 19;36(48):7430-7437. doi: 10.1016/j.vaccine.2018.05.035. Epub 2018 May 19.
6
Vaccines for epidemic infections and the role of CEPI.针对传染病的疫苗和 CEPI 的作用。
Hum Vaccin Immunother. 2017 Dec 2;13(12):2755-2762. doi: 10.1080/21645515.2017.1306615. Epub 2017 Apr 4.
7
[Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].[全球卫生治理的困境、成因与对策：以新冠疫苗全球获取机制为例]
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Apr 10;43(4):483-487. doi: 10.3760/cma.j.cn112338-20211216-00987.
8
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
9
IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?IABS/CEPI 平台技术网络研讨会：是否有可能缩短疫苗研发时间？
Biologicals. 2021 Jun;71:55-60. doi: 10.1016/j.biologicals.2021.04.005. Epub 2021 May 7.
10
Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need.关于研发基孔肯雅病毒疫苗及确保有需要国家公平获取疫苗的战略考量。
NPJ Vaccines. 2023 Aug 18;8(1):123. doi: 10.1038/s41541-023-00722-x.
引用本文的文献
1
Past, present, and future: a situational analysis of infectious disease modelling in Thailand.过去、现在与未来：泰国传染病建模的情境分析
Lancet Reg Health Southeast Asia. 2025 Jun 26;39:100618. doi: 10.1016/j.lansea.2025.100618. eCollection 2025 Aug.
2
The resurgence of monkeypox virus: a critical global health challenge and the need for vigilant intervention.猴痘病毒的卷土重来：一项严峻的全球卫生挑战以及进行警惕干预的必要性。
Front Public Health. 2025 May 30;13:1572100. doi: 10.3389/fpubh.2025.1572100. eCollection 2025.
3
Structural biology of Nipah virus G and F glycoproteins: Insights into therapeutic and vaccine development.尼帕病毒G和F糖蛋白的结构生物学：对治疗和疫苗开发的见解
Eur J Microbiol Immunol (Bp). 2025 Apr 22;15(2):83-93. doi: 10.1556/1886.2025.00017. Print 2025 Jun 30.
4
'Our project, your problem?' A case study of the WHO's mRNA technology transfer programme in South Africa.“我们的项目，你的问题？” 世界卫生组织在南非的信使核糖核酸技术转让计划案例研究
PLOS Glob Public Health. 2024 Sep 23;4(9):e0003173. doi: 10.1371/journal.pgph.0003173. eCollection 2024.
5
Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens.快速诊断检测：高优先级病原体爆发防范和应对的关键需求。
BMJ Glob Health. 2024 Apr 30;9(4):e014386. doi: 10.1136/bmjgh-2023-014386.
6
Geographical and practical challenges in the implementation of digital health passports for cross-border COVID-19 pandemic management: a narrative review and framework for solutions.地理和实际挑战在数字健康护照的实施跨境 COVID-19 大流行管理:叙事审查和解决方案的框架。
Global Health. 2023 Dec 8;19(1):98. doi: 10.1186/s12992-023-00998-7.
7
We must revise the current logic to protect our humanity from Infectious disease outbreaks.我们必须修正当前的逻辑，以保护人类免受传染病爆发的影响。
J Public Health Afr. 2023 Oct 1;14(9):2829. doi: 10.4081/jphia.2023.2829.
8
Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.南尼日利亚孕妇中拉沙病毒的血清流行病学：一项前瞻性基于医院的队列研究。
PLoS Negl Trop Dis. 2023 May 22;17(5):e0011354. doi: 10.1371/journal.pntd.0011354. eCollection 2023 May.
9
Global health landscape challenges triggered by COVID-19.由新冠疫情引发的全球卫生格局挑战。
Inflamm Regen. 2020 Sep 15;40:34. doi: 10.1186/s41232-020-00144-5. eCollection 2020.
10
Bridging the gap: advancing multipurpose prevention technologies from the lab into the hands of women†.缩小差距：推动多用途预防技术从实验室走向女性手中†
Biol Reprod. 2020 Aug 4;103(2):286-288. doi: 10.1093/biolre/ioaa085.
本文引用的文献
1
How COVID vaccines shaped 2021 in eight powerful charts.新冠疫苗如何通过八张有力图表塑造了2021年。
Nature. 2021 Dec;600(7890):580-583. doi: 10.1038/d41586-021-03686-x.
2
COVID-19 Pandemic as an Excellent Opportunity for Global Health Diplomacy.COVID-19 大流行是全球卫生外交的绝佳机会。
Front Public Health. 2021 Jul 12;9:655021. doi: 10.3389/fpubh.2021.655021. eCollection 2021.
3
Assessing how global health partnerships function: an equity-informed critical interpretive synthesis.评估全球卫生伙伴关系如何运作：基于公平性的批判性解释性综合分析。
Global Health. 2021 Jul 2;17(1):73. doi: 10.1186/s12992-021-00726-z.
4
A beautiful idea: how COVAX has fallen short.一个美好的设想：新冠疫苗全球获取机制（COVAX）为何未达预期。
Lancet. 2021 Jun 19;397(10292):2322-2325. doi: 10.1016/S0140-6736(21)01367-2.
5
Fairer shares.更公平的份额。
Science. 2021 May 28;372(6545):903-906. doi: 10.1126/science.372.6545.903.
6
International collaboration and covid-19: what are we doing and where are we going?国际合作与新冠疫情：我们正在做什么以及将走向何方？
BMJ. 2021 Jan 28;372:n180. doi: 10.1136/bmj.n180.
7
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.mRNA 疫苗对 SARS-CoV-2 的作用-初步报告。
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
8
COVID-19 vaccines for all?全民接种新冠疫苗？
Lancet. 2020 Jun 13;395(10240):1822-1823. doi: 10.1016/S0140-6736(20)31354-4.
Zotero 插件